Memorial Sloan Kettering medical oncologist Mark Kris has been named the lead physician for the institution’s IBM Watson collaboration.
Medical oncologist Mark G. Kris has been named Lead Physician, Memorial Sloan Kettering-IBM Watson Collaboration.
Over the past year, Dr. Kris and colleagues at Memorial Sloan Kettering have worked with an IBM team to develop a powerful cancer resource built on the IBM Watson system that will provide medical professionals with improved access to current and comprehensive cancer data and practices. As Lead Physician of the Memorial Sloan Kettering-IBM Watson Collaboration, Dr. Kris will spearhead the effort to train the IBM Watson supercomputer to learn everything it can about cancer care and how Memorial Sloan Kettering experts use medical information and their experience in personalizing cancer treatments. This new decision-support tool will eventually help physicians everywhere create individualized cancer diagnostic and treatment recommendations for their patients.
Dr. Kris — who has stepped down as Chief of the Thoracic Oncology Service after serving in that role since 1990 — specializes in the care of people with cancers arising in the chest, including lung cancer, thymoma, mediastinal tumors, and cancers of unknown primary origin. He is also a researcher, with a particular interest in finding ways to select the best treatments for patients with cancers based on the molecular characteristics of tumors.